Skip to main content
HealthPartners

Coverage criteria policies

Breast surgery

These services may or may not be covered by your HealthPartners plan. Please see your plan documents for your specific coverage information. If there is a difference between this general information and your plan documents, your plan documents will be used to determine your coverage.

Administrative Process

Prior authorization is not required for:

  • Breast reconstruction following a covered mastectomy or lumpectomy (including surgery for asymmetry)
  • Breast reconstruction for Poland syndrome

Prior authorization is required for:

  • Augmentation mammoplasty not related to a mastectomy/lumpectomy
  • Mastopexy (breast lift) not related to a mastectomy/lumpectomy
  • Breast reconstruction to correct a congenital defect other than Poland syndrome
  • Breast implant removal and/or replacement not related to a mastectomy/lumpectomy

This policy does not address

  • Reduction mammoplasty not related to a mastectomy/lumpectomy
  • Surgery for gynecomastia. Please see Related Content at right for links to coverage criteria.

Coverage

Breast surgery is generally covered subject to the indications listed below and per your plan documents.

  • Breast reconstruction following a covered mastectomy or lumpectomy is covered. This may include the following procedures:
    • TRAM flap or similar type of reconstructive breast surgery,
    • augmentation mammoplasty (including implant placement),
    • autologous fat injection/ transfer
    • insertion of tissue expanders
    • use of acellular dermal matrix products; and
    • nipple and areolar reconstruction, (including tattooing) of the affected breast.
  • Surgery on the contralateral (unaffected) breast is covered following a covered mastectomy or lumpectomy to produce a symmetrical appearance. This may include the following procedures:
    • augmentation mammoplasty (including implant placement),
    • mastopexy (breast lift), and/or
    • reduction mammoplasty (breast reduction).
  • Surgical revision of tissue protruding at the end of a scar (sometimes referred to as a “dog ear” or standing cone) is covered when related to a covered mastectomy/ lumpectomy.

Indications that are covered

Breast reconstruction to correct a congenital defect
  1. Requests for reconstructive breast surgery for congenital syndromes that are directly associated with the absence of breasts (e.g., ectodermal dysplasia), for which member has tried and failed conservative treatment measures (such as appropriate hormone therapies where considered a standard of care), are reviewed on a case by case basis by a medical director.
Implant Removal and/or Replacement (not applicable when member has had a covered mastectomy or lumpectomy):
  1. Removal of implants is covered when the original implants were placed for a covered condition.
  2. Removal of implants that were placed for a non-covered condition is only covered when painful capsular contracture is present.
  3. Removal of silicone implants is covered when there is documented evidence of leaking causing medical complications.
  4. Breast implant replacement is covered when the original implants, which were placed for a covered condition, have been removed.

Indications that are not covered

  1. The following procedures, when not related to a covered mastectomy or lumpectomy, are considered cosmetic and not medically necessary. This includes but is not limited to:
    1. Breast reconstruction or augmentation for asymmetrical / hypoplastic / aplastic breasts that do not result from an underlying congenital diagnosis
    2. Removal of breast implants to improve appearance, regardless of why the implants were placed
    3. Mastopexy (breast lift)
    4. Correction of involution (shrinkage) or ptosis (drooping)
    5. Removal of extra axillary breast tissue
    6. Removal of supernumerary (more than two) nipples
    7. Correction of tuberous breast deformity
    8. Correction of inverted nipples
  2. Screening using MRI, ultrasound, etc. to determine implant rupture or leaking in asymptomatic individuals is not covered as it is not medically necessary.

Definitions

Acellular dermal matrix (ADM) is used for soft tissue replacement for breast reconstruction after mastectomy. It provides biologic scaffolding that assists in formation of connective tissue as it stabilizes the position of the pectoralis major muscle in order to prevent upward migration of the muscle. Products include AlloDerm, AlloMax, DermACELL, DermaMatrix, FlexHD, Strattice and SeriSurgical Scaffold

Aplasia is a lack of development of an organ or tissue or of the cellular products from an organ or tissue.

Autologous fat transfer (also called autologous fat grafting or fat injection) involves the removal and relocation of the patient’s own body fat (usually from the abdomen, buttocks or thighs). Liposuction is used to remove the fat, which is then processed and injected into the breast.

Breast implant is a bag or pouch filled with a solution and placed under the skin to rebuild the breast after mastectomy or to enhance the size of a breast in cosmetic breast augmentation surgery.

Breast reconstruction is a procedure in which an expander or an implant or tissue from other parts of the body is used to rebuild the breast.

Ectodermal dysplasias are a group of approximately 150 related disorders that result from faulty development of the ectodermal germ cell layer during embryogenesis. Hypohidrotic ectodermal dysplasia is one form of this condition that can result in amastia (absence of the entire breast). This form can also impact the development or function of the hair, nails, sweat glands and teeth.

Hypoplasia is the incomplete development or under development of an organ or tissue.

Mastopexy, also known as a breast lift, is a procedure which raises the breasts by removing excess skin and tightening the surrounding tissue to reshape and support the new breast contour.

Poland syndrome is a rare congenital condition that causes chest wall deformity. People with Poland Syndrome are missing at least part of the muscle from one side of their chest, sometimes missing one or more rib(s), and may have only one fully developed breast/nipple.

If available, codes are listed below for informational purposes only, and do not guarantee member coverage or provider reimbursement. The list may not be all-inclusive.

The services associated with these CPT codes require prior authorization, regardless of diagnosis:

CPT Code

Description

19318

Reduction mammaplasty

19328

Removal of intact mammary implant

19330

Removal of mammary implant material

19355

Correction of inverted nipples

19370

Incision of capsule surrounding breast with freeing of scar tissue, open procedure

19371

Periprosthetic capsulectomy, breast

The services associated with these CPT codes require prior authorization, except when billed with an ICD-10 diagnosis code listed below.

CPT Code

Description

19316

Mastopexy

19324

Mammaplasty, augmentation: without prosthetic implant

19325

Mammaplasty, augmentation: with prosthetic implant

19340

Immediate insertion of breast prosthesis following mastopexy, mastectomy or in reconstruction

19342

Delayed insertion of breast prosthesis following mastopexy, mastectomy or in reconstruction

19350

Nipple/areola reconstruction

19380

Revision of reconstructed breast

19396

Preparation of moulage for custom breast implant

ICD-10 Code

Description

C50.011

Malignant neoplasm of nipple and areola, right female breast

C50.012

Malignant neoplasm of nipple and areola, left female breast

C50.019

Malignant neoplasm of nipple and areola, unspecified female breast

C50.111

Malignant neoplasm of central portion of right female breast

C50.112

Malignant neoplasm of central portion of left female breast

C50.119

Malignant neoplasm of central portion of unspecified female breast

C50.211

Malignant neoplasm of upper-inner quadrant of right female breast

C50.212

Malignant neoplasm of upper-inner quadrant of left female breast

C50.219

Malignant neoplasm of upper-inner quadrant of unspecified female breast

C50.311

Malignant neoplasm of lower-inner quadrant of right female breast

C50.312

Malignant neoplasm of lower-inner quadrant of left female breast

C50.319

Malignant neoplasm of lower-inner quadrant of unspecified female breast

C50.411

Malignant neoplasm of upper-outer quadrant of right female breast

C50.412

Malignant neoplasm of upper-outer quadrant of left female breast

C50.419

Malignant neoplasm of upper-outer quadrant of unspecified female breast

C50.511

Malignant neoplasm of lower-outer quadrant of right female breast

C50.512

Malignant neoplasm of lower-outer quadrant of left female breast

C50.519

Malignant neoplasm of lower-outer quadrant of unspecified female breast

C50.611

Malignant neoplasm of axillary tail of right female breast

C50.612

Malignant neoplasm of axillary tail of left female breast

C50.619

Malignant neoplasm of axillary tail of unspecified female breast

C50.811

Malignant neoplasm of overlapping sites of right female breast

C50.812

Malignant neoplasm of overlapping sites of left female breast

C50.819

Malignant neoplasm of overlapping sites of unspecified female breast

C50.911

Malignant neoplasm of unspecified site of right female breast

C50.912

Malignant neoplasm of unspecified site of left female breast

C50.919

Malignant neoplasm of unspecified site of unspecified female breast

C79.81

Secondary malignant neoplasm of breast

D05.00

Lobular carcinoma in situ of unspecified breast

D05.01

Lobular carcinoma in situ of right breast

D05.02

Lobular carcinoma in situ of left breast

D05.1

Intraductal carcinoma in situ of breast

D05.10

Intraductal carcinoma in situ of unspecified breast

D05.11

Intraductal carcinoma in situ of right breast

D05.12

Intraductal carcinoma in situ of left breast

D05.8

Other specified type of carcinoma in situ of breast

D05.80

Other specified type of carcinoma in situ of unspecified breast

D05.81

Other specified type of carcinoma in situ of right breast

D05.82

Other specified type of carcinoma in situ of left breast

D05.9

Unspecified type of carcinoma in situ of breast

D05.90

Unspecified type of carcinoma in situ of unspecified breast

D05.91

Unspecified type of carcinoma in situ of right breast

D05.92

Unspecified type of carcinoma in situ of left breast

N65.0

Deformity of reconstructed breast

N65.1

Disproportion of reconstructed breast

Q79.8

Poland syndrome

Z42.1

Encounter for breast reconstruction following mastectomy

Z85.3

Personal history of malignant neoplasm of breast

Z86.000

Personal history of in-situ neoplasm of breast

Z90.10

Acquired absence of unspecified breast and nipple

Z90.11

Acquired absence of right breast and nipple

Z90.12

Acquired absence of left breast and nipple

Z90.13

Acquired absence of bilateral breasts and nipples

CPT Copyright American Medical Association. All rights reserved. CPT is a registered trademark of the American Medical Association.

Products

This information is for most, but not all, HealthPartners plans. Please read your plan documents to see if your plan has limits or will not cover some items. If there is a difference between this general information and your plan documents, your plan documents will be used to determine your coverage. These coverage criteria may not apply to Medicare Products if Medicare requires different coverage. For more information regarding Medicare coverage criteria or for a copy of a Medicare coverage policy, contact Member Services at 952-883-7979 or 1-800-233-9645.

References

  1. American Society of Plastic Surgeons. (2015). Post-mastectomy fat graft/ fat transfer ASPS guiding principles. Available from www.plasticsurgery.org
  2. Banikarim, C., & De Silva, N. K. Breast disorders in children and adolescents. In: UpToDate, Drutz, J. E., Middleman, A. B. (Eds), UpToDate, Waltham, MA. (Accessed on February 15, 2019.)
  3. Cher, D. J., Conwell, J. A., Mandel, J. S. (2001). MRI for detecting silicone breast implant rupture: meta-analysis and implications. Annals of Plastic Surgery, 47(4), 367-380.
  4. ECRI Institute. (2017). Cosmetic Areola Micropigmentation after Postmastectomy Breast Reconstruction. Plymouth Meeting, PA: ECRI Institute.
  5. Hayes, Inc. Hayes Health Technology Brief. Autologous Fat Grafting for Breast Reconstruction After Breast Cancer Surgery. Lansdale, PA: Hayes, Inc.; August, 2015. Archived September, 2018.
  6. Hayes, Inc. Hayes Medical Technology Directory Report. Comparative Effectiveness Review: Human Acellular Dermal Matrix for Breast Reconstruction. Lansdale, PA: Hayes, Inc.; January, 2019.
  7. Minnesota Statutes, §62A.25 Reconstructive Surgery (2018).
  8. Nahabedian, M. Implant-based breast reconstruction and augmentation. In: UpToDate, Butler, C E. (Ed), UpToDate, Waltham, MA. (Accessed on February 15, 2019.)
  9. Nahabedian, M. Complications of reconstructive and aesthetic breast surgery. In: UpToDate, Butler, C. E.(Ed), UpToDate, Waltham, MA. (Accessed on February 15, 2019.)
  10. Women's Health and Cancer Rights Act of 1998, 9 U.S.C. §§901-903 (2012).

Go to

Policy activity

  • 07/01/1995 - Date of origin
  • 05/01/2019 - Effective date
Review date
  • 02/2019
Revision date
  • 04/05/2019

Related content